325sek
-2,1 %
Date:2025-05-14Time:15:49:31Latest report:Q3-2024List:First NorthTicker:ACOU
Market Cap:69 msekEnterprise Value:59 msekNet Sales:3,52 msekEarnings:-18,8 msekEmployees:0ISIN:SE0009189608

Ratios

10-year key figure history for AcouSort turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for AcouSort with index and moving average MA50 and MA200.

Stockprice:3,25
MA50:3,94
MA200:10,57
Price/MA200:-69,3 %
RSI (14):34,1
Price/MA50:-17,4 %

Description

AcouSort is active within medical technology. The company conducts research and development in a proprietary platform technology that utilises ultrasound to separate and analyse composition of biological cells. The technology is mainly used in the analysis of various cases of cancer as well as sepsis. Part of the research is done together with other stakeholders within field. The company was founded in 2010 and is based in Lund.

Biotechnology